Canna Care Docs

NOVEMBER 4, 2024

cannabis has been used medicinally as a treatment for pain and other ailments. Today, you can explore personalized treatment plans to aid your distinctive needs. Patients with these conditions frequently seek relief from a variety of traditional treatments. Medicine and orthopedic concept. Since 2727 B.C.

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. THC VS. CBD. Find Out if You Qualify. Get Started. Join 46K+ Subscribers!

Data 114

Data Chronic Pain Sleep Patients 114

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Over the prior three years or so, 41,260 RYAH-connected patients reported medical cannabis use for the treatment of pain. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. The reference data it collects and its constantly improving machine learning algorithms create a moat that prevents competitors from quickly stepping into the market.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JUNE 23, 2021

Medicann is launching an observational study using RYAH Smart Dry Herb Inhalers in order to collect patient feedback on consumption of cannabis strains available on the Island, including strains supplied by Aurora Europe , a subsidiary of Canadian-headquartered Aurora Cannabis Inc., Forward-Looking Statements.

Programs 100

Programs Data Events Collective 100

Canna Care Docs

SEPTEMBER 18, 2020

To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy. You may schedule online at cannacaredocs.com/virginia/.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

JULY 7, 2021

is a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments. It is working to provide the critical infrastructure needed to develop and deliver breakthrough mental health treatments. KetamineOne Capital Limited (formerly Myconic Capital Corp.) On behalf of: KETAMINE ONE.

Research and Development 98

Research and Development Treatment Therapy Banking 98

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Pharmaceutical 76

Pharmaceutical Research and Development Sativa Extraction 76

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Additionally, there were several instances in which cepharanthine displayed growth inhibition which was comparable or superior to current gold standard treatments, including colorectal, liver and skin cancers.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JULY 28, 2021

Additionally, as previously announced on January 21, 2021, Unifor and Aleafia entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents that receive medical cannabis insurance coverage clinics through Unifor’s collective bargaining agreements. The recent addition of KGK Science Inc.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. brands, including Lord Jones. We are delighted to have Lord Jones involved in the Radicle Sciences’ ACES study. Eric Schudiske, eric@s2spr.com.

CBD 81

CBD Data Sleep Clinical Trials 81

Cannabis Law Report

JUNE 16, 2021

“Santé is a key partner to for Wake as they are a leading contract research organization (CRO) in Canada with expertise in advancing plant-based pharmaceutical products through various phases of clinical trial development. We are excited to explore the potential of emergent psychedelic therapies.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 19, 2021

Philip Morris International recently offered £1 billion to buy Vectura Group PLC, the British pharmaceutical company that develops inhaled medical products. The global market for inhalation drug delivery devices is predicted to reach $17.6 billion by 2027. About RYAH Group, Inc. Forward-Looking Statements.

Therapy 76

Therapy Data Research and Development Events 76

NORML

FEBRUARY 8, 2019

Activists in Mississippi have already collected thousands of signatures in hopes of qualifying a medical cannabis ballot initiative for the 2020 ballot. The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil. OR resident?

Legislation 196

Legislation Decriminalization Patients Access 196

The Blunt Truth

APRIL 20, 2021

The term does not include industrial hemp, as defined in state law, that is grown, dealt, or processed in compliance with state or federal law, unless it has been acquired and formulated with cannabis plant extract by a pharmaceutical processor. Next Steps for Employers.

Recreational 77

Recreational Legalization Oil Extraction 77

United Patients Group

MAY 17, 2023

collecting items related to trains). Recently, a pharmaceutical company has created a cannabis based isolate, meaning one cannabinoid, in this case CBD called Epidiolex which is available by prescription in all 50 states. Emotions and Behaviors Autism spectrum disorder (ASD) is a spectrum disorder that affects people in different ways.

Sleep 105

Sleep Cannabinoids Patients CBD 105

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

Cannabis Law Report

JANUARY 15, 2019

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Epilepsy 71

Epilepsy Cannabinoids Treatment Research and Development 71

Puff Puff Post

MAY 28, 2019

Her previous use of pharmaceutical medications provided only minor relief that came with a slew of side-effects. This makes it more effective for short-term treatment for sleep issues as opposed to long-term. Every day we learn more and more about the amazing relief CBD can provide for sleep and other ailments.

Sleep 18

Sleep Oil CBD Tincture 18

CannaTech

SEPTEMBER 23, 2019

This bottleneck has left patients and parents to pursue unregulated avenues to access treatment. Furthermore, pharmaceutical companies often fund and initiate randomised clinical trials to validate their drugs. It is tragic that in the UK, cannabis is denied to the most vulnerable citizens.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

JULY 19, 2021

We are delighted to partner with Knowde Group Inc and offer our clients access to expert trialists in pharmaceutical based clinical research that will translate well into the plant based and progressive medicines space. As a decentralized CRO, Knowde Group can engage and manage clinical trials around the globe.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Cannabis Law Report

MARCH 22, 2020

The questionnaire asks a patient’s symptoms, if they are concerned about contracting COVID-19, what conditions they are currently treating with medical cannabis or other pharmaceuticals and how effective they feel those treatments to be. The brief survey can be taken here.

THC 59

THC Clinical Trials Data Consumption 59

SpeedWeed

MARCH 30, 2021

At this stage we need a middle ground and establishing a registry to collect data is a sensible way forward and will be very useful. “It It is going to allow us to collect data that can be shared on how cannabis medicines are prescribed and the benefits patients get.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

OCTOBER 5, 2021

This scientific and commercial excitement rests on research showing that psychedelics can supercharge mental health treatment for PTSD, depression, anxiety, addiction, and other chronic ailments of the mind, enabling patients to dive deep, confront their traumas and — a rarity for mental illnesses — return healed,” the article reads.

Therapy 52

Therapy Pharmaceutical Collective Treatment 52

SpeedWeed

MAY 17, 2021

Officials suspended him without pay and forced him to enter a substance abuse treatment program. At this point, the fire department terminated his employment, based on the rules of his union’s collective bargaining agreement. “They are seven years behind.”

Legalization 52

Legalization Chronic Pain Collective State Laws 52

Cannabis Law Report

MARCH 16, 2022

The team collectively has managed thousands of clinical trials and has achieved numerous regulatory approvals including therapeutics, diagnostics and devices and the Company has filed sixteen patent applications to date on its discovery accomplishments.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Medicine 52

SpeedWeed

AUGUST 11, 2021

“Suicide among veterans is an urgent public health crisis, but it’s solvable if we invest in researching new treatments for pain, depression, and PTSD,” said Sisley in a press statement. Results of this study showed evidence of the pros and cons to cannabis as a treatment for PTSD patients. The study was funded with $2.2

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

JUNE 29, 2022

With the interest in potential utility of cannabis to develop treatments for a variety of medical conditions and the continued issuance of cannabis patents, the number of cannabis patent proceedings is likely to increase as well. Pure Hemp Collective, Inc. Pure Hemp Collective, Inc. United Cannabis Corporation v.

Research and Development 52

Research and Development Extraction Pharmaceutical Hemp 52

Otherside Farms

JANUARY 25, 2019

When you consider that the majority of MMJ patients suffer from chronic pain (88% in Colorado) and that narcotic pain medications are dirt cheap when purchased through legitimate channels, it doesn’t take a high IQ to figure out that the pharmaceutical companies would love to corner this market.

Marijuana 68

Marijuana Strains Medicine Chronic Pain 68

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

SEPTEMBER 29, 2022

Medicinal cannabis companies that falsely claimed their prescription products could treat serious conditions, such as cancer and epilepsy, have received a collective fine of almost $1m by Australia’s drugs regulator. Three medicinal cannabis companies fined almost $1 million for alleged unlawful advertising. 27 September 2022.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Veriheal

JULY 5, 2021

In spite of their fairly equal dominance in the legal cannabis space—collectively, these cannabinoids racked up $17.5 Titled “ The Effectiveness of Common Cannabis Products for Treatment of Nausea ”, the newly published study indicates that most medical cannabis patients who endure nausea prefer to load up on THC, as opposed to CBD.

THC 52

THC CBD Treatment Cannabinoids 52